Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) — Capital Reinvestment Ratio
Latest as of March 2025:
5.82x
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a Capital Reinvestment Ratio of 5.82x as of March 2025, meaning it reinvests 6% of its operating cash flow (Rs8.95 Million) in capital expenditures (Rs52.04 Million). See AAREYDRUGS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
5.82x
Capex / Operating Cash Flow
Operating Cash Flow
Rs8.95 Million
INR
Capital Expenditures
Rs52.04 Million
INR
Data as of
Mar 2025
Most recent filing
Aarey Drugs & Pharmaceuticals Limited Capital Reinvestment Ratio (2009–2025)
This chart tracks Aarey Drugs & Pharmaceuticals Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Aarey Drugs & Pharmaceuticals Limited (2009–2025)
Year-by-year Capital Reinvestment Ratio for Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. For live market cap and broader valuation context, see AAREYDRUGS company net worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.82x | Rs8.95 Million | Rs52.04 Million | ▲ +1006.4% |
| 2021 | 0.53x | Rs54.77 Million | Rs28.79 Million | ▲ +63.5% |
| 2020 | 0.32x | Rs28.57 Million | Rs9.19 Million | ▼ -82.0% |
| 2019 | 1.78x | Rs6.89 Million | Rs12.28 Million | ▼ -65.2% |
| 2017 | 5.13x | Rs9.62 Million | Rs49.35 Million | ▲ +1025.9% |
| 2016 | 0.46x | Rs56.59 Million | Rs25.78 Million | ▼ -39.0% |
| 2015 | 0.75x | Rs32.53 Million | Rs24.31 Million | ▲ +1423.2% |
| 2013 | 0.05x | Rs33.72 Million | Rs1.65 Million | ▼ -99.7% |
| 2009 | 18.99x | Rs302.06K | Rs5.73 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow